| Literature DB >> 29207957 |
Yabin Hu1,2, Kun Huang3,4, Yuanfang Sun1,2, Jianqing Wang1,2, Yeqing Xu5, Shuangqin Yan5, Peng Zhu1,2, Fangbiao Tao1,2.
Abstract
BACKGROUND: Caesarean delivery rate is increasing gradually in China and there is no doubt that delivery mode is closely associated with the maternal health and infant development.This study examined the independent effect of delivery mode on placenta inflammation response and oxidative stress response.Entities:
Keywords: Delivery mode; Inflammation; Oxidative stress; Placenta
Mesh:
Substances:
Year: 2017 PMID: 29207957 PMCID: PMC5718001 DOI: 10.1186/s12884-017-1589-9
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Fig. 1Participants recruitment flow chart. ICP intrahepatic cholestasis of pregnancy; HDCP hypertension disorders complicating pregnancy; GDM gestational diabetes mellitus; VD vaginal delivery; CDMI cesarean delivery with medical indication; CDMR cesarean delivery on maternal request; UCD urgent cesarean delivery
Maternal and infants’ characteristics in 4 kinds of delivery modes
| Characteristics | VD | CDMI | CDMR | UCD |
|
|---|---|---|---|---|---|
| Maternal characteristics | |||||
| Maternal age(years) | 25.95 ± 3.02 | 27.41 ± 3.83 | 26.48 ± 3.73 | 27.15 ± 2.87 | <0.001 |
| Gestational age(weeks) | 39.20 ± 1.22 | 39.12 ± 1.37 | 39.29 ± 1.06 | 39.15 ± 1.18 | 0.191 |
| Gravidity | 1.55 ± 0.80 | 1.83 ± 1.04 | 1.65 ± 0.86 | 1.72 ± 0.83 | <0.001 |
| Pre-pregnancy BMI(kg/m2) | 19.96 ± 2.32 | 20.73 ± 2.75 | 20.44 ± 2.66 | 20.88 ± 2.71 | <0.001 |
| Previous adverse pregnant outcome | 638(61.9%) | 187(54.0%) | 317(57.7%) | 24(51.1%) | 0.032 |
| Pregnancy-specific anxiety score in 1st trimester | 20.26 ± 4.82 | 19.80 ± 4.26 | 20.55 ± 5.13 | 19.55 ± 3.72 | 0.191 |
| Pregnancy-specific anxiety score in 2nd trimester | 19.61 ± 4.44 | 19.91 ± 4.62 | 19.92 ± 4.90 | 19.27 ± 3.84 | 0.459 |
| Pregnancy-specific anxiety score in 3rd trimester Infants’ characteristics | 18.72 ± 4.00 | 18.96 ± 4.30 | 19.17 ± 4.63 | 18.76 ± 3.43 | 0.245 |
| Gender | 0.174 | ||||
| Male | 544(52.8%) | 163(46.8%) | 281(50.9%) | 28(59.6%) | |
| Female | 487(47.2%) | 185(53.2%) | 271(49.1%) | 19(40.4%) | |
| Birth weight(g) | 3304.81 ± 379.63 | 3443.95 ± 467.26 | 3417.05 ± 397.17 | 3481.70 ± 350.30 | <0.001 |
| Birth height(cm) | 50.13 ± 1.71 | 50.03 ± 1.76 | 49.95 ± 1.51 | 50.70 ± 1.54 | 0.013 |
| Head circumference(cm) | 33.82 ± 1.30 | 34.33 ± 1.73 | 34.20 ± 1.46 | 34.14 ± 2.04 | <0.001 |
| Placental size(cm3) | 685.79 ± 180.12 | 815.70 ± 224.56 | 799.87 ± 207.96 | 754.31 ± 230.07 | <0.001 |
| Apgar score | |||||
| 1-Min | 9.95 ± 0.46 | 9.94 ± 0.53 | 9.97 ± 0.42 | 9.91 ± 0.46 | 0.784 |
| 5-Min | 9.98 ± 0.23 | 9.99 ± 0.16 | 10.00 ± 0.04 | 10.00 ± 0.00 | 0.219 |
VD vaginal delivery, CDMI cesarean delivery with medical indication, CDMR cesarean deliveryon maternal request, UCD urgent cesarean delivery, BMI body mass index; data presented with mean ± SD and n(%)
Maternal placental mRNA expression of cytokines in 4 kinds of delivery modes (mean ± SE)
| Cytokines | VD | CDMI | CDMR | UCD |
|
|---|---|---|---|---|---|
| Pro-inflammatory cytokines | |||||
| IL-1β | 0.98 ± 0.04 | 0.85 ± 0.07 | 0.77 ± 0.06 | 1.04 ± 0.22 | 0.042 |
| TNF-α | 1.36 ± 0.05 | 1.47 ± 0.08 | 1.59 ± 0.06 | 1.84 ± 0.23 | 0.007 |
| IL-6 | 0.73 ± 0.04 | 0.85 ± 0.06 | 0.90 ± 0.06 | 1.02 ± 0.22 | 0.063 |
| IFN-γ | 1.18 ± 0.06 | 1.12 ± 0.09 | 1.15 ± 0.07 | 1.59 ± 0.25 | 0.399 |
| IL-8 | 0.87 ± 0.04 | 0.65 ± 0.07 | 0.55 ± 0.06 | 0.96 ± 0.20 | <0.001 |
| Anti-inflammatory cytokines | |||||
| IL-4 | 0.93 ± 0.05 | 0.81 ± 0.08 | 0.89 ± 0.06 | 1.19 ± 0.22 | 0.354 |
| IL-10 | 1.07 ± 0.05 | 0.99 ± 0.08 | 0.96 ± 0.07 | 1.11 ± 0.23 | 0.538 |
| Oxidative stress cytokines | |||||
| HO-1 | 0.91 ± 0.04 | 1.09 ± 0.08 | 1.15 ± 0.06 | 0.90 ± 0.16 | 0.009 |
VD vaginal delivery, CDMI cesarean delivery with medical indication, CDMR cesarean deliveryon maternal request, UCD urgent cesarean delivery
Adjusted effect of delivery modes on quintiles of IL-1β, TNF-α, IL-6, IFN-γ, IL-8, IL-10 and HO-1 mRNA expression of maternal placenta
| Cytokines | Groups | Quantile regressions | ||||
|---|---|---|---|---|---|---|
| 10th | 25th | 50th | 75th | 90th | ||
| IL-1β | CDMI | 0.11(−0.28,0.51) | 0.03(−0.21,0.26) | −0.26(−0.51,-0.01)* | −0.20(−0.49,0.09) | −0.23(−0.59,0.13) |
| CDMR | 0.09(−0.25,0.43) | −0.14(−0.38,0.10) | −0.23(−0.50,0.03) | −0.30(−0.43,-0.17)* | −0.45(−0.67,-0.22)* | |
| UCD | 0.43(−0.35,1.21) | 0.39(−0.14,0.92) | −0.07(−0.57,0.44) | −0.01(−0.58,0.58) | −0.41(−1.53,0.71) | |
| TNF-α | CDMI | 0.20(−0.21,0.62) | 0.15(−0.19,0.49) | 0.12(−0.11,0.34) | −0.01(−0.30,0.28) | −0.02(−0.47,0.44) |
| CDMR | 0.31(−0.04,0.67) | 0.27(−0.06,0.60) | 0.20(−0.02,0.41) | 0.03(−0.21,0.27) | 0.06(−0.19,0.31) | |
| UCD | 0.34(−0.51,1.19) | 0.36(−0.19,0.90) | −0.02(−0.83,0.79) | −0.06(−1.36,1.24) | 1.11(−0.60,2.83) | |
| IL-6 | CDMI | 0.56(0.30,0.81)* | 0.04(−0.12,0.20) | 0.11(−0.07,0.28) | −0.06(−0.30,0.19) | 0.06(−0.25,0.38) |
| CDMR | 0.39(0.55,0.73)* | 0.15(−0.03,0.33) | 0.19(−0.03,0.41) | 0.27(0.09,0.45)* | 0.20(0.06,0.35)* | |
| UCD | 0.37(−0.50,1.25) | 0.26(−0.10,0.62) | 0.58(−0.41,0.53) | −0.31(−0.92,0.29) | 0.64(−1.38,2.65) | |
| IFN-γ | CDMI | 0.20(−0.31,0.71) | 0.12(−0.32,0.57) | −0.15(−0.46,0.17) | −0.14(−0.40,0.11) | −0.20(−0.69,0.28) |
| CDMR | 0.12(−0.25,0.48) | 0.17(−0.39,0.72) | −0.07(−0.35,0.20) | −0.25(−0.48,-0.02)* | −0.23(−0.62,0.15) | |
| UCD | −0.13(−2.21,1.94) | 0.32(−0.45,1.10) | 0.05(−1.15,1.26) | 0.33(−0.65,1.31) | 0.26(−0.45,0.97) | |
| IL-8 | CDMI | 0.03(−0.21,0.28) | −0.17(−0.48,0.14) | −0.21(−0.53,0.11) | −0.32(−0.63,-0.01)* | −0.37(−0.62,-0.13)* |
| CDMR | −0.07((−0.30,0.16) | −0.34(−0.56,-0.11)* | −0.40(−0.64,-0.16)* | −0.40(−0.63,-0.17)* | −0.29(−0.53,-0.06)* | |
| UCD | 0.15(−0.36,0.67) | −0.27(−0.90,0.36) | −0.01(−0.71,0.70) | 0.10(−0.96,1.16) | −0.19(−1.25,0.86) | |
| IL-10 | CDMI | −0.06(−0.34,0.23) | −0.02(−0.31,0.27) | 0.01(−0.34,0.35) | 0.03(−0.44,0.49) | 0.07(−0.24,0.38) |
| CDMR | −0.02(−0.27,0.23) | −0.15(−0.41,0.11) | −0.19(−0.45,0.07) | 0.01(−0.42,0.43) | 0.26(−0.23,0.75) | |
| UCD | −0.17(−1.00.0.65) | 0.07(−0.50,0.65) | −0.19(−0.76,0.38) | −0.71(−1.13,-0.29)* | −0.35(−1.70,1.00) | |
| HO-1 | CDMI | 0.18(−0.28,0.64) | 0.25(0.04,0.45)* | 0.30(0.10,0.50)* | 0.01(−0.25,0.26) | 0.31(−0.09,0.71) |
| CDMR | 0.13(−0.17,0.43) | 0.24(−0.04,0.52) | 0.37(0.21,0.53)* | 0.23(−0.01,0.48) | 0.41(0.04,0.78)* | |
| UCD | 0.11(−0.74,0.96) | 0.26(−0.33,0.84) | −0.01(−0.31,0.28) | 0.17(−0.68,1.02) | −0.18(−0.74,0.39) | |
Data were presented by quantile regression coefficients and 95% CIs (Confidence intervals) which based on above cytokines mRNA expression. Vaginal delivery group was regarded as control; CDMI cesarean delivery with medical indication, CDMR cesarean deliveryon maternal request, UCD urgent cesarean delivery
Model was adjusted by these variables: pre pregnancy BMI, maternal age, gravidity, previous adverse pregnant outcome, pregnancy-specific Anxiety Score in 1st, 2nd and 3rd trimester, birth weight, gestational age, infant gender and placental size
*P values less than 0.05 were considered significant (two-sided)